Such elevated IL-32 mRNA levels were found to be associated with body mass index (BMI), aminotransferases, NAFLD activity score, and homeostasis model assessment of insulin resistance (HOMA-IR) index (72). This evidence concerns the gene IL32 and metabolic dysfunction-associated steatotic liver disease.